tiprankstipranks
Daiichi Sankyo Company Limited (DSKYF)
OTHER OTC:DSKYF
US Market
DSKYF
Daiichi Sankyo Company
RESEARCH TOOLSreports
Want to see DSKYF full AI Analyst Report?

Daiichi Sankyo Company (DSKYF) Stock News & Sentiment

63 Followers
DSKYF Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
DSKYF Upcoming Earnings Report: What to Expect?
9d ago
Daiichi Sankyo Advances ADC Pipeline With New Esophageal Cancer Study
Premium
Company Announcements
Daiichi Sankyo Advances ADC Pipeline With New Esophageal Cancer Study
15d ago
DSKYF
Daiichi Sankyo Terminates Early Cancer Trial DS-9606a: What Investors Should Know
Premium
Company Announcements
Daiichi Sankyo Terminates Early Cancer Trial DS-9606a: What Investors Should Know
1M ago
DSKYF
Daiichi Sankyo Backs Triple Cholesterol Therapy in New Phase 3 Heart Study
Premium
Company Announcements
Daiichi Sankyo Backs Triple Cholesterol Therapy in New Phase 3 Heart Study
2M ago
DSKYF
Daiichi Sankyo Advances Triple Cholesterol Combo Pill With Completed Bioequivalence Study
Premium
Company Announcements
Daiichi Sankyo Advances Triple Cholesterol Combo Pill With Completed Bioequivalence Study
2M ago
DSKYF
Bayer and Daiichi Sankyo Advance New Prostate Cancer Combo in Early-Stage Trial
Premium
Company Announcements
Bayer and Daiichi Sankyo Advance New Prostate Cancer Combo in Early-Stage Trial
3M ago
Daiichi Sankyo Reports January Progress on Ongoing Share Buyback Program
Premium
Company Announcements
Daiichi Sankyo Reports January Progress on Ongoing Share Buyback Program
3M ago
More DSKYF News >

DSKYF News on the Web

Daiichi Sankyo Advances ADC Pipeline With New Esophageal Cancer Study
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Daiichi Sankyo Company (OtherDSKYF) and Arcutis Biotherapeutics (ARQT)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM), Maze Therapeutics, Inc. (MAZE) and Daiichi Sankyo Company (OtherDSKYF)
TipRanks News
Bullish
Daiichi Sankyo Terminates Early Cancer Trial DS-9606a: What Investors Should Know
TipRanks News
Bearish
Daiichi Sankyo Backs Triple Cholesterol Therapy in New Phase 3 Heart Study
TipRanks News
Neutral
Daiichi Sankyo Company (DSKYF) Receives a Buy from Nomura
TipRanks News
Bullish
Daiichi Sankyo: FDA Grants Priority Review For ENHERTU
rttnews
Bullish
Daiichi Sankyo Advances Triple Cholesterol Combo Pill With Completed Bioequivalence Study
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
DSKYF
Sector Average
Media Buzz
This Week2 articles
Weekly Average0.75 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DSKYF’s Media Buzz Sentiment?
2 articles about DSKYF were published this week. In an average week, 0.75 articles are published.
    What is DSKYF’s weekly average amount of articles?
    In an average week, 0.75 articles about DSKYF are published.
      What is DSKYF’s News Sentiment?
      100% of articles about DSKYF were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week